Before they became the doctors, nurses and misfits of the 4077th, the cast of M*A*S*H followed very different paths to get ...

The 2026 MLB regular season got fully underway today with 11 games across the slate. The Mets won the first game of the day, overpowering the Pirates in an 11-7 after Paul Skenes lasted just 37 ...

Opening day in Baltimore is more than a game — it’s a citywide celebration, and The Baltimore Sun is bringing you right into the heart of it. Join us live from Oriole Park at Camden Yards for two ...

This Orioles season could serve as the fulcrum in the current era of Baltimore baseball. A bounce-back campaign would put the Orioles right back on track. But another losing season would have massive ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...

Bret Bloomquist can be reached at [email protected]; @Bretbloomquist on X.

On Wednesday, the regular season begins and the San Francisco Giants have the honor of throwing out the first pitch. The Giants will host the New York Yankees on Wednesday night at Oracle Park in the ...

For 11 seasons, MASH was one of the most popular sitcoms on television. In fact, the show had so many fans who loved it that its final episode, “Goodbye, Farewell and Amen,” was the most-watched ...

The New Jersey-founded chain opened the doors to its new spot in Main Street in the former home of Chutni Biryani & Noodle Bar and Tasty Taco. The soft opening of the restaurant took place Feb. 26.

Jay N. Yepuri, MD, MS, FACG, is a board-certified gastroenterologist and member of the Digestive Health Associates of Texas Board of Directors and Executive Committee. MASH is the updated term for ...

Forbes contributors publish independent expert analyses and insights. Emily writes about what’s in your glass and why it matters. If you’ve spent time reading bourbon labels or poking around ...

After cutting down its pipeline just a few months ago, OSE Immunotherapeutics is at it again, this time reorganizing as Boehringer Ingelheim walks away from the biotech’s metabolic ...